Where does V-Wave Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), V-Wave Ltd. ranks #6,855 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does V-Wave Ltd. hold?

V-Wave Ltd. holds 49 US utility patents granted between 2015 and 2025, spanning 3 technology areas.

What is V-Wave Ltd.'s Innovation Score?

V-Wave Ltd. has an Innovation Score of 41.3 out of 100 (top 34% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is V-Wave Ltd.'s patent grant rate increasing or decreasing?

V-Wave Ltd.'s recent grant velocity is +86% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for V-Wave Ltd.'s patents?

V-Wave Ltd.'s patents average 22.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the V-Wave Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

V-Wave Ltd.

Q: What technology areas does V-Wave Ltd. focus on?

V-Wave Ltd.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 47 patents, ranking #129 of 3,082 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 49 granted patents across 3 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, V-wave ranks #6,855 of 49,997 tracked US assignees by granted-patent volume, with 49 patents across 3 technology areas.

#6,855
of 49,997 US assignees by volume: Top 34%
by Innovation Score (41.3/100): 22.6
avg claims per patent: +86%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6855 · Foreign Corporation #6,855 · 49 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 49 grants
UPPER-Q #6,855/49,997
PHOTO-FINISH Tyco AMP Korea
CPC-NARROW A61F · 3 areas
INNOV-PAR 41.3/100
CLAIMS-DENSE 22.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +86% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Tyco Electronics AMP Korea Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How V-wave’s 41.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.5 pts (33%) Velocity 8.1 pts (20%) Breadth 6.1 pts (15%) Claim depth 13.5 pts (33%)

Qualcomm Incorporated · highest

85
Amdocs Software… · near

41
Liebherr-mining… · near

41
Solazyme · near

41
V-Wave · this assignee

41
Ii-vi Incorporated · near

41
3D Lighting… · lowest

7

What this shows V-wave's Innovation Score is 41.3/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for V-wave?

Each dot is one of V-wave’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). V-wave’s own 22.6 claims/patent is ABOVE the 16.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

V-wave vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where V-wave's grants concentrate

V-Wave Ltd. is a focused PatentsView assignee: 3 CPC subclasses with 95.9% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2022 (8 grants) versus a trough of 1 in 2015. By volume, V-wave sits between Tyco Electronics AMP Korea Co., Ltd. and Welldoc, Inc..

V-wave's three-year grant acceleration

V-Wave Ltd. shows 17 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Tyco AMP Korea

49
University Public…

49
UniversitÉ Cathol…

49
Ultratech

49
Varel Internation…

49
W&H Dentalwerk Bü…

49
Walter

49
Welldoc

49
V-wave ◀

49

What this shows V-Wave holds 49 patents at rank #6,855, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near V-Wave

By rank, the assignees closest to #6,855 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in V-Wave's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for V-Wave, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), V-Wave ranks #129 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

Amdocs Software Systems Limited 41 Solazyme, Inc. 41 Liebherr-mining Equipment Colmar SAS 41 Ii-vi Incorporated 41

V-wave's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

V-Wave Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	2.0%
2017	5	10.2%
2018	3	6.1%
2019	5	10.2%
2020	3	6.1%
2021	6	12.2%
2022	8	16.3%
2023	6	12.2%
2024	3	6.1%
2025partial year	9	18.4%

Which technologies does V-Wave Ltd. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 47

A61B - DIAGNOSIS; SURGERY; Identification 43

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 31

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

V-Wave Ltd.'s patent record in context - here's where to go next.

V-Wave Ltd.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 95.9% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #6,855 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare V-Wave Ltd. against Tyco Electronics AMP Korea Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.